[1]
“ASSESSMENT OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY ”, Int. Res. J. Pharm., vol. 10, no. 1, pp. 160–164, Jan. 2019, Accessed: Jul. 30, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/244